The store will not work correctly when cookies are disabled.
3-hydroxy-1-(4-phenylpyridin-2-yl)pyridin-4(1H)-one
ID: ALA3799913
PubChem CID: 67419505
Max Phase: Preclinical
Molecular Formula: C16H12N2O2
Molecular Weight: 264.28
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers
Canonical SMILES: O=c1ccn(-c2cc(-c3ccccc3)ccn2)cc1O
Standard InChI: InChI=1S/C16H12N2O2/c19-14-7-9-18(11-15(14)20)16-10-13(6-8-17-16)12-4-2-1-3-5-12/h1-11,20H
Standard InChI Key: QWTHMOHMTPERDO-UHFFFAOYSA-N
Molfile:
RDKit 2D
20 22 0 0 0 0 0 0 0 0999 V2000
2.5987 -1.5004 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.2990 -0.7500 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
1.2990 0.7500 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.0000 1.5000 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.2990 0.7500 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.2990 -0.7500 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.0000 -1.5000 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.3383 1.3500 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-2.3383 -1.3500 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
3.8991 -0.7525 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
5.1969 -1.5045 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.1945 -3.0045 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.8943 -3.7525 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.5965 -3.0004 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.8919 -5.2532 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.1886 -6.0075 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.1838 -7.5075 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.8824 -8.2533 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.5858 -7.4992 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.5905 -5.9992 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2 3 1 0
2 7 1 0
3 4 2 0
4 5 1 0
5 6 1 0
6 7 2 0
1 2 1 0
5 8 2 0
6 9 1 0
1 10 2 0
10 11 1 0
11 12 2 0
12 13 1 0
13 14 2 0
14 1 1 0
15 16 2 0
16 17 1 0
17 18 2 0
18 19 1 0
19 20 2 0
20 15 1 0
13 15 1 0
M END
Associated Targets(Human)
Associated Targets(non-human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 264.28 | Molecular Weight (Monoisotopic): 264.0899 | AlogP: 2.61 | #Rotatable Bonds: 2 |
Polar Surface Area: 55.12 | Molecular Species: NEUTRAL | HBA: 4 | HBD: 1 |
#RO5 Violations: ┄ | HBA (Lipinski): 4 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: 10.91 | CX Basic pKa: 4.68 | CX LogP: 3.18 | CX LogD: 3.17 |
Aromatic Rings: 3 | Heavy Atoms: 20 | QED Weighted: 0.77 | Np Likeness Score: -0.66 |
References
1. Zhao Z, Harrison ST, Schubert JW, Sanders JM, Polsky-Fisher S, Zhang NR, McLoughlin D, Gibson CR, Robinson RG, Sachs NA, Kandebo M, Yao L, Smith SM, Hutson PH, Wolkenberg SE, Barrow JC.. (2016) Synthesis and optimization of N-heterocyclic pyridinones as catechol-O-methyltransferase (COMT) inhibitors., 26 (12): [PMID:27133481] [10.1016/j.bmcl.2016.03.095] |